Default Category
-
Predilytics
Higgins, Robert F.; Lobb, AnnelenaCase HBS-813023-EEntrepreneurshipThe management team at Predilytics, a healthcare analytics firm, must decide whether to accept a Series A venture capital financing deal. The company provided analytic services to healthcare plans, typically Medicare Advantage plans, in efforts to draw conclusions from massive amounts of patient data. The company still had enough funding from a seed round to operate on a low-key basis for a few more months, but the team hoped to move forward aggr...Starting at €8.20
-
Entrepreneurship in Healthcare IT Services (EHITS) Fall Term 2013: Course Outline and Syllabus, Course Overview Note
Higgins, Robert F.Case HBS-814022-EEntrepreneurshipThis is the syllabus and course outline for "Entrepreneurship in Healthcare IT and Services (EHITS), taught by Prof. Bob Higgins in the fall of 2013. Contains the course overview, objectives, goals and themes.Starting at €8.20
-
Steward Health Care System
Higgins, Robert F.; Fisher, NoahCase HBS-814029-EEntrepreneurshipSteward Health has raised private equity and has converted from not-for-profit to for-profit. The case describes its Accountable Care Organization (ACO) and asks whether it should continue this experiment.Starting at €8.20
-
A Note on Healthcare IT and Applications to the Healthcare Industry
Higgins, Robert F.; Maichin, DianaCase HBS-814033-EEntrepreneurshipThis note provides an overview of three key healthcare IT areas: electronic medical records and electronic health records, revenue cycle management, and telemedicine. This note also contains a glossary of key terms and acronyms in this space as well as exhibits detailing unit economics, market dynamics, and key players.Starting at €8.20
-
RedBrick Health: How to Fatten the Company That Slims...
Higgins, Robert F.; Greenglass, Robert M.Case HBS-815035-EEntrepreneurshipThe case describes this health and wellness service company and poses the question: should RedBrick stay on the path of building out its product platform or should the RedBrick platform be launched directly to health insurers, ACOs, or directly to customers?Starting at €8.20
-
Michael Rubin and Fanatics (A)
Higgins, Robert F.; Masko, JohnCase HBS-819077-EEntrepreneurshipIn 2016, Michael Rubin's Fanatics was the U.S.' largest sports e-commerce company, and operator of the official online store for all the major American sports leagues. That year, Fanatics began to dabble in manufacturing licensed sports merchandise, securing limited permissions from leagues to manufacture apparel in response to 'micro-moments,' sudden surges of interest in a team or player that were too abrupt for the league's usual licensees to ...Starting at €8.20
-
Michael Rubin and Fanatics (B)
Higgins, Robert F.; Masko, JohnCase HBS-819082-EEntrepreneurshipStarting at €5.74
-
Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech
Higgins, Robert F.; Kazan, BrentCase HBS-808005-EFinanceIn 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora Biosciences. The combination of Vertex's and Aurora's technologies would improve the flow of novel drug candidates into development. However, several questions related to the integration of Aurora into Vertex were still unresolved, the most pressing being Aurora's major collaboration with the Cystic Fibrosis Foundation (CFF). Were venture philanthrop...Starting at €8.20
-
STRIVR: Changing the Game in Virtual Reality
Lal, Rajiv; Denison, Matt; Higgins, Robert F.; Johnson, ScottCase HBS-518048-EMarketingThe CEO of a growing virtual reality company that trains athletes must decide whether or not to stay in sports or expand into other areas.Starting at €8.20
-
Claritas Genomics
Higgins, Robert F.; Preble, MatthewCase HBS-814032-EEntrepreneurshipClaritas Genomics was formed in January 2013 when BCH spun out its Genetics Diagnostic Lab into a fully commercial entity. Claritas offered over 100 genomic tests to detect a range of conditions, including autism and intellectual disabilities, and was developing new tests that provided clearer and more relevant information for physicians to use in treating patients. Claritas wanted to increase the speed at which genomic research discoveries occur...Starting at €8.20